Growth Metrics

Armata Pharmaceuticals (ARMP) Assets Average (2016 - 2018)

Historic Assets Average for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q3 2018 value amounting to $11.2 million.

  • Armata Pharmaceuticals' Assets Average fell 2266.76% to $11.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was $11.2 million, marking a year-over-year decrease of 2266.76%. This contributed to the annual value of $14.6 million for FY2017, which is 4100.03% down from last year.
  • Per Armata Pharmaceuticals' latest filing, its Assets Average stood at $11.2 million for Q3 2018, which was down 2266.76% from $13.1 million recorded in Q2 2018.
  • Armata Pharmaceuticals' Assets Average's 5-year high stood at $39.4 million during Q1 2014, with a 5-year trough of $11.2 million in Q3 2018.
  • Its 5-year average for Assets Average is $25.3 million, with a median of $28.8 million in 2016.
  • In the last 5 years, Armata Pharmaceuticals' Assets Average surged by 829.95% in 2015 and then plummeted by 4889.12% in 2017.
  • Quarter analysis of 5 years shows Armata Pharmaceuticals' Assets Average stood at $30.3 million in 2014, then increased by 8.3% to $32.8 million in 2015, then plummeted by 32.61% to $22.1 million in 2016, then plummeted by 43.61% to $12.5 million in 2017, then dropped by 10.35% to $11.2 million in 2018.
  • Its Assets Average stands at $11.2 million for Q3 2018, versus $13.1 million for Q2 2018 and $12.8 million for Q1 2018.